Y-Intercept (HK)
HUMA icon

Y-Intercept (HK)’s Humacyte HUMA Stock Holding History

Y-Intercept (HK)’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-87,705
Closed -$68.4K – 1794
2026
Q2 		$68.4K Buy
+87,705
New +$81.3K ﹤0.01% 1618
2023
Q2 		– Sell
-14,565
Closed -$45K – 1468
2023
Q1 		$45K Buy
+14,565
New +$41.4K 0.01% 1105
2022
Q2 		– Sell
-17,125
Closed -$121K – 1003
2022
Q1 		$121K Buy
+17,125
New +$100K 0.03% 659

Other funds holding HUMA

Miramontes Capital
Miramontes Capital Newport, California $331M AUM 19.33% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Clarus Wealth Advisors
Clarus Wealth Advisors Peoria, Arizona $275M AUM 18.32% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Columbia Advisory Partners
Columbia Advisory Partners Spokane, Washington $181M AUM 18.7% 1-Year Est. Return
Hamilton Lane Advisors
Hamilton Lane Advisors Conshohocken, Pennsylvania $179M AUM 25.1% 1-Year Est. Return
Trilogy Capital
Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return
Onyx Bridge Wealth Group
Onyx Bridge Wealth Group Tarrytown, New York $1.14B AUM 18.43% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return
Brookstone Capital Management
Brookstone Capital Management Wheaton, Illinois $10.1B AUM 17.94% 1-Year Est. Return

Y-Intercept (HK)'s HUMA Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Humacyte (HUMA) in Q3 2026, closing a stake of 87,705 shares — an estimated $68.4K sold.

Y-Intercept (HK) first reported a position in HUMA in Q1 2022 and held it in 3 quarters. The position peaked at $121K in Q1 2022. 23 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Humacyte position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 87,705 Humacyte shares in Q3 2026, an estimated $68.4K.
  • Y-Intercept (HK) first reported a position in Humacyte in Q1 2022 and held it in 3 quarters.
  • Y-Intercept (HK)'s Humacyte position peaked at $121K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.